Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-02-09

Clinical Trial Update: Trial Comparing Haloperidol, Quetiapine and Placebo in the Pharmacological Treatment of Delirium [Phase 3]

View source ↗

Summary

Phase 3 trial comparing haloperidol, quetiapine, and placebo for treatment of delirium has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • HALOPERIDOL (HALOPERIDOL LACTATE)
  • Quetiapine (quetiapine)

Snippet

Sponsor: Centre hospitalier de l'Université de Montréal (CHUM) | Conditions: Delirium | Phase 3 | Status: COMPLETED